To analyse appearance of skin after treatment with steroid ointments and creams using a special magnifying device
Not Applicable
- Conditions
- Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2021/01/030664
- Lead Sponsor
- Dr Aravind S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients started on a topical steroid for the first time from our department
Patients already on topical steroid with or without features of topical steroid abuse
Exclusion Criteria
Patients unwilling to give consent
Patients below 18 years of age
Patients already treated with long term oral steroid or other immunosuppressants
Patients planned for oral steroid treatment
Patients having comorbidities that resemble or can cause changes similar to topical steroid side effects (e.g., polycystic ovaries/Cushingâ??s syndrome/thyroid disorders)
Patients undergoing intralesional steroid injection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Enumerate and describe the clinical features in steroid applied skin of different duration <br/ ><br>Enumerate and describe the dermoscopic findings in steroid applied skin of different duration <br/ ><br>Compare between perilesional steroid applied skin and morphologically similar normal skin, clinically as well as dermoscopically in view of describing any steroid-induced early changesTimepoint: At baseline
- Secondary Outcome Measures
Name Time Method Attempt at classifying clinical and dermoscopic changes of steroid use depending upon the potency of the agent used and duration of the application <br/ ><br>Study the progressive steroid-induced changes in steroid naïve patients who are started on topical steroids and who come for follow up at various intervalsTimepoint: At the end of study (Nov 2021)